Ariez B.V.

Prof. Alexander Eggermont

Ariez Publishing

Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.

0:00 | 10:09

In this podcast, Prof. Eggermont discusses the results of the PIVOT-12 trial, which investigates the potential of bempegaldesleukin combined with nivolumab as adjuvant treatment after complete melanoma resection in patients with a high risk of recurrence.